80~20000pg/ML N-Terminal Atrial Natriuretic Peptide Precursor Detection Reagent(NT-ProBNP) Performance Index
NT-proBNP Overview
N-terminal atrial natriuretic peptide precursor (NT-proBNP) is a peptide hormone secreted by the heart. It is an important regulator of the pathology and physiology of heart failure. It is of high value for the diagnosis and prognosis evaluation of heart failure. Recommended indicators for the European Society of Cardiology (ESC) and Heart Failure Diagnosis and Treatment Guidelines.
NT-proBNP Performance Index
| Detection range | sample size | Sample type | Test time |
| 80~20000pg/mL | 60μl | Whole blood / serum / plasma | 15min |
NT-proBNP Clinical significance
- Early diagnosis of heart failure and risk stratification
- Evaluate and monitor the prognosis of heart failure
- Distinguish between heart failure and dyspnea caused by other causes
- Assist in ACS risk stratification
- High-risk population screening
| Acute heart failure |
| Age | NT-proBNP(pg/ml) | Diagnosis of heart failure |
| It's not about age | <300 | Eliminate the possibility of heart failure |
| < 50 years old | 300-450 | Heart failure is less likely to be diagnosed in combination with other clinical manifestations |
| 50-75 years old | ≧450 | High probability of heart failure |
| 300-900 | Heart failure is less likely to be diagnosed in combination with other clinical manifestations |
| ≧900 | High probability of heart failure |
| >75 years old | 300-1800 | Heart failure is less likely to be diagnosed in combination with other clinical manifestations |
| ≧1800 | High probability of heart failure |
| Chronic heart failure |
| It's not about age | <400 | Eliminate heart failure |
| 400- 2000 | The clinical manifestations of the patients should be collected, and the electrocardiogram, chest radiograph and echocardiography should be used for multi-index differential diagnosis |
| ≧2000 | High possibility of heart failure |
Application Department
Cardiology, emergency, ICU, respiratory, laboratory, surgery, neurology, obstetrics and Gynecology, oncology, etc
NT-proBNP Clinical comparison
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.
